Pharmlog Pharma Logistik
Pharmlog Pharma Logistik, headquartered in Germany, is a leading player in the pharmaceutical logistics industry, specialising in the efficient and secure transportation of medical products. Founded in 2003, the company has established a strong presence across Europe, with key operational regions including Germany, Austria, and Switzerland. Pharmlog offers a range of services, including temperature-controlled logistics, warehousing, and distribution, tailored specifically for the pharmaceutical sector. Their commitment to quality and compliance with stringent regulatory standards sets them apart in the market. Recognised for their innovative solutions and reliability, Pharmlog has achieved significant milestones, positioning itself as a trusted partner for pharmaceutical companies seeking to optimise their supply chains. With a focus on customer satisfaction and operational excellence, Pharmlog continues to enhance its reputation in the logistics landscape.
DitchCarbon Score
How does Pharmlog Pharma Logistik's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmlog Pharma Logistik's score of 12 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmlog Pharma Logistik's reported carbon emissions
In 2022, PharmLog Pharma Logistik reported total greenhouse gas emissions of approximately 6,692,000 kg CO2e. This figure includes 1,425,000 kg CO2e from Scope 1 emissions, 242,000 kg CO2e from Scope 2 emissions, and a significant 6,616,000 kg CO2e from Scope 3 emissions. The company has set ambitious targets to reduce its greenhouse gas emissions, committing to a 46% reduction in Scope 1 and Scope 2 emissions by 2030, using 2019 as the baseline year. This target has been validated by the Science Based Targets initiative (SBTi) and aligns with the necessary reductions to limit global warming to 1.5°C. PharmLog is also focused on measuring and reducing its Scope 3 emissions, which encompass a wide range of indirect emissions from its value chain.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Scope 1 | 332,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 304,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 348,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmlog Pharma Logistik is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
